OpenVSafe by OpenVAERS
Search V-safe

BD5-17961-89581

2 vaccinations 5 coded responses 6 check-ins 5 free-text entries 4 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
770 / TX
Registered
2021-03-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-18
    Dose 1 — Moderna
  2. 2021-02-22
    Dose 2 — Moderna
  3. 2021-03-26
    Registered in v-safe
  4. 2021-03-26
    Survey response — day 28, dose 2
    MedDRA: Headache, Nausea, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Nausea and headaches but symptoms are also common with my NMO.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-29
    Survey response — day 35, dose 2
    MedDRA: Decreased appetite, Headache, Nausea — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Headache, nausea and loss of appetite worse.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-29
    Report sent to call center — day 35, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-04-05
    Survey response — day 42, dose 2
    MedDRA: Decreased appetite, Dyspnoea, Headache, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Shortness of breath. Loss of appetite. Worse headaches that may be associated with NMO.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-05
    Report sent to call center — day 42, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-05-26
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  10. 2021-08-25
    Survey response — 6 months, dose 2
    MedDRA: Muscular weakness, Neuromyelitis optica spectrum disorder, Pain, Visual impairment — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Recovering from NMO related problems middle of July. Vision worse and more leg weakness. Increased pain.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  11. 2021-08-25
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-08-27
  13. 2022-02-22
    Survey response — 12 months, dose 2
    MedDRA: Decubitus ulcer, Hospitalisation, Meningitis, Ophthalmic herpes zoster, Sinusitis, Surgery, Urinary tract infection — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Hospital where I had shingles virus in eye, meningitis in brain and eye, UTI, pressure wounds and sinus infection that required surgery.
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-02-22
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  15. 2022-02-23
  16. 2022-02-28

Vaccinations

DoseDateManufacturerCo-administered
12021-01-18Moderna
22021-02-22Moderna

Call center

4 call center cases

4 unsuccessful

See the call center timeline

Free text

Release 6 — day 28, dose 2

2021-03-26

Symptoms: Nausea and headaches but symptoms are also common with my NMO.

Release 6 — day 35, dose 2

2021-03-29

Symptoms: Headache, nausea and loss of appetite worse.

Release 6 — day 42, dose 2

2021-04-05

Symptoms: Shortness of breath. Loss of appetite. Worse headaches that may be associated with NMO.

Release 9 — 6 months, dose 2

2021-08-25

Symptoms: Recovering from NMO related problems middle of July. Vision worse and more leg weakness. Increased pain.

Release 11 — 12 months, dose 2

2022-02-22

Symptoms: Hospital where I had shingles virus in eye, meningitis in brain and eye, UTI, pressure wounds and sinus infection that required surgery.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDecreased appetite ✓ ✓ ✓
SDDecubitus ulcer · · ✓
SDDyspnoea ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHospitalisation · · ✓
SDMeningitis · · ✓
SDMuscular weakness ✓ · ✓
SDNausea ✓ ✓ ✓
SDNeuromyelitis optica spectrum disorder ✓ · ✓
SDOphthalmic herpes zoster · · ✓
SDPain ✓ · ✓
SDPre-existing disease ✓ ✓ ✓
SDSinusitis · · ✓
SDSurgery · · ✓
SDUrinary tract infection · · ✓
SDVisual impairment ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release